Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection, Human Immunodeficiency Virus I”

725 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 725 results

Early research (Phase 1)Study completedNCT00002009
What this trial is testing

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Early research (Phase 1)Study completedNCT02413645
What this trial is testing

Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients

Who this might be right for
HIV-infection
Judit Pich Martínez 21
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Early research (Phase 1)Study completedNCT03391375
What this trial is testing

Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 Trial

Who this might be right for
HIV/AIDS
EuroVacc Foundation 49
Testing effectiveness (Phase 2)Study completedNCT02906007
What this trial is testing

Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

Who this might be right for
TuberculosisHIV
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT00000632
What this trial is testing

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 14
Early research (Phase 1)Looking for participantsNCT07530198
What this trial is testing

HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong

Who this might be right for
Human Immunodeficiency VirusHuman Immunodeficiency Virus I Infection
Immuno Cure Holding (HK) Limited 22
Early research (Phase 1)Study completedNCT01353716
What this trial is testing

Dolutegravir Renal Impairment Study

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 16
Early research (Phase 1)Study completedNCT00002006
What this trial is testing

A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableStudy completedNCT00002299
What this trial is testing

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT00031044
What this trial is testing

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Early research (Phase 1)Study completedNCT03441984
What this trial is testing

To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers

Who this might be right for
HIV Infections
ViiV Healthcare 36
Early research (Phase 1)Study completedNCT00001026
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Looking for participantsNCT06034938
What this trial is testing

DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)

Who this might be right for
Hiv
University Hospital, Caen 32
Testing effectiveness (Phase 2)Study completedNCT00799058
What this trial is testing

A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States

Who this might be right for
HIV-1 Infections
International Partnership for Microbicides, Inc. 128
Early research (Phase 1)Study completedNCT00336778
What this trial is testing

Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression

Who this might be right for
HIV Infections
University of Maryland, Baltimore 6
Early research (Phase 1)Study completedNCT00000667
What this trial is testing

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00261001
What this trial is testing

Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route

Who this might be right for
Healthy VolunteersHIV Infection
Objectif Recherche Vaccins SIDA 38
Load More Results